Clinical Trial Update: Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial shows improvement in liver function in patients with liver cirrhosis after autologous mesenchymal stem cell injections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Liver Failure

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Liver Failure, Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED